Skip to content
Cover of TAG's 2022 Annual Report. Progress in the Fight for Better Treatment, Prevention, A Vaccine, and a Cure for HIV, Tuberculosis, and Hepatitis C Virus.

2022 Annual Report

  • Dorrit Walsh
As we close another year of unprecedented challenges and achievements, I'm honored to share with you Treatment Action Group's (TAG) 2022 Annual Report.
Read more

TAG’s Submission to OHCHR for GA78 Report

  • Dorrit Walsh
TAG recently submitted this input for the Office of the High Commissioner on Human Rights (ONHCR) Independent Expert on Foreign Debt and Human Rights thematic report for the UN General Assembly 78 later this year.
Read more

Research in Action Awards 2023

  • Dorrit Walsh
Save the date for Monday, October 19! TAG’s 2023 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world.
Read more
cover of publication, black with white and red text that reads: 35 years of Art fo end AIDS

35 Years of Art to End AIDS Exhibition Catalog

  • Dorrit Walsh
TAG is presenting the exhibition “35 Years of Art to End AIDS” at Melissa Morgan Fine Art in Palm Desert, California, from March 17 through April 7, 2023. This exhibit features selected works form our Limited Art Editions collection.
Read more
Cover of report - HIV Cure research information sheet

HIV Cure Research Information Sheet

  • Dorrit Walsh
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.
Read more

For Us By Us: PrEP in Black America

  • Dorrit Walsh
For Us By Us: PrEP in Black America, A Master Plan for HIV Prevention in Black America is a collaborative project from the PrEP in Black America coalition, which includes Treatment Action Group, PrEP4All, AVAC, Atlanta Black Women Leaders on PrEP, Equity & Impact Solutions, iStrive, Positive Impact Health Centers, and Red Hot.
Read more
Back To Top